Fig. 1

Expression and immunological characteristics of ZNF529-AS1 in different cancers. A The Wilcoxon rank sum test was used to analyse the differential expression of ZNF529-AS1 in tumour tissues and adjacent tissues. B The Wilcoxon rank sum test was used to analyse the differential expression of ZNF529-AS1 in normal adjacent tissues of GTEx-bound TCGA and tumour tissues of TCGA. C Differential expression of ZNF529-AS1 in tumour samples and matched adjacent samples. D ROC curve shows the efficiency of the ZNF529-AS1 expression level to distinguish HCC tissues from nontumor tissues. The X-axis denotes the false-positive rate, and the Y-axis denotes the true positive rate. E–H Heatmaps show the relationship between ZNF529-AS1 and H MHC molecules, F chemokines, G receptors and H immune checkpoints. For each relationship, the upper-left triangle is coloured to denote the p value, and the lower-right triangle is coloured to denote the correlation coefficient